A 2-month-old boy with hemolytic anemia and reticulocytopenia following intravenous immunoglobulin therapy for Kawasaki disease: a case report and literature review
Na Yeon Kim (Kim NY), Joon Hwan Kim (Kim JH), Jin Suk Park (Park JS), Soo Hyun Kim (Kim SH), Yeon Kyung Cho (Cho YK), Dong Hyun Cha (Cha DH), Ki Eun Kim (Kim KE), Myung Suh Kang (Kang MS), Kyung Ah Lim (Lim KA), Youn Ho Sheen (Sheen YH)
Clin Exp Pediatr. 2016;59(Suppl 1):S60-S63.   Published online 2016 Nov 30     DOI: https://doi.org/10.3345/kjp.2016.59.11.S60
Citations to this article as recorded by Crossref logo
Acute and Chronic Dosing of a High-Affinity Rat/Mouse Chimeric Transferrin Receptor Antibody in Mice
Demi M. Castellanos, Jiahong Sun, Joshua Yang, Weijun Ou, Alexander C. Zambon, William M. Pardridge, Rachita K. Sumbria
Pharmaceutics.2020; 12(9): 852.     CrossRef
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease
Samantha C. Roberts, Sonia Jain, Adriana H. Tremoulet, Katherine K. Kim, Jane C. Burns, Vikram Anand, Marsha Anderson, Jocelyn Ang, Emily Ansusinha, Moshe Arditi, Negar Ashouri, Allison Bartlett, Archana Chatterjee, Roberta DeBiasi, Cornelia Dekker, Chand
Contemporary Clinical Trials.2019; 79: 98.     CrossRef
Adverse Effects of Immunoglobulin Therapy
Yi Guo, Xin Tian, Xuefeng Wang, Zheng Xiao
Frontiers in Immunology.2018;[Epub]     CrossRef
High‚Äźdose intravenous immunoglobulin is strongly associated with hemolytic anemia in patients with Kawasaki disease
Brian E. Nolan, Yunfei Wang, Philippe P. Pary, Naomi L.C. Luban, Edward C.C. Wong, Tova Ronis
Transfusion.2018; 58(11): 2564.     CrossRef
Immune globulin
Reactions Weekly.2017; 1633(1): 392.     CrossRef